United States Cancer Biopsy Market was valued at USD 1.80 Billion in 2022 and is projected to reach USD 3.00 Billion by 2030, growing at a CAGR of 7.30% from 2024 to 2030.
Start
The Us Cancer Biopsy Market Has Experienced Significant Growth In Recent Years, Driven By Advancements In Diagnostic Technologies, Increasing Cancer Incidence, And The Growing Demand For Early-Stage Detection. With A Vast Array Of Biopsy Types, Each Tailored For Specific Cancers, This Market Is Pivotal To The Healthcare Industry. The Major Types Of Biopsies Include Needle Biopsy, Surgical Biopsy, And Liquid Biopsy, With Each Serving Distinct Clinical Needs Depending On The Type And Location Of Cancer.
The Increasing Demand For Precision Medicine And Personalized Healthcare Has Directly Impacted The Cancer Biopsy Market. Healthcare Providers And Industries Are Now More Focused On Molecular Profiling, Enabling More Accurate Diagnosis And Targeted Therapies. This Growing Shift Towards Genetic Testing And Advanced Diagnostics Has Opened New Opportunities For Companies Involved In Biopsy Technologies, Encouraging Them To Innovate Continuously. Biopsy Requirements Are No Longer Limited To Physical Tissue Samples; Liquid Biopsy Technologies Are Increasingly Gaining Attention As They Offer Non-Invasive Testing Options That Provide High Accuracy In Early Detection.
In Addition To Technological Advancements, The Rising Need For Cancer Biopsies In The Industrial Sector Is Driven By The Prevalence Of Cancer Across Various Demographics. Medical Device Manufacturers, Diagnostic Labs, And Pharmaceutical Companies All Require High-Quality Biopsy Products To Ensure Accurate Diagnostic Results. These Industries Rely Heavily On Cancer Biopsy Innovations To Meet The Needs Of Healthcare Professionals Who Strive For Timely And Effective Treatments. The Market Is Now Highly Competitive, With Many Players Constantly Developing Better Biopsy Techniques And Devices.
Furthermore, With The Rising Healthcare Expenditure In The Us, The Need For Efficient And Cost-Effective Cancer Biopsy Solutions Is Pushing For Greater Investments In R&D And Collaborations Between Biotech Companies, Research Institutions, And Hospitals. In This Competitive Environment, Having Reliable And Innovative Biopsy Technology Is Essential For Success In The Cancer Diagnosis And Treatment Sectors.
Despite Challenges Such As High Costs And The Need For Specialized Training, The Us Cancer Biopsy Market Continues To Grow. The Expansion Of This Market, Along With The Increasing Demand For Advanced Biopsy Techniques, Will Ultimately Improve The Efficiency And Accessibility Of Cancer Diagnostics Across The Nation.
Get an In-Depth Research Analysis of the US Cancer Biopsy Market Size And Forecast [2025-2032]
Â
Qiagen N.V.
Illumina
Inc
ANGLE Plc
Myriad Genetics
Hologic
Inc
Biocept
Inc
Thermo Fisher Scientific
Inc
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL
Inc
Guardant Health
Exact Sciences Corporation
Freenome Holdings
Inc
Oncimmune
Chronix Biomedical
Inc
Personal Genome Diagnostics Inc
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Cancer Biopsy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Cancer Biopsy Market
Needle Biopsy
Excisional Biopsy
Incisional Biopsy
Endoscopic Biopsy
Fine-Needle Aspiration Biopsy (FNAB)
Imaging-guided Biopsy
Optical Biopsy
Molecular Biopsy
Liquid Biopsy
Electromagnetic Navigation Biopsy
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Gynecological Cancer
Hospitals
Diagnostic Laboratories
Research Institutions
Specialty Clinics
Ambulatory Surgical Centers
Tissue Samples
Blood Samples
Saliva Samples
Urinary Samples
Bone Marrow Samples
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Cancer Biopsy Market Research Analysis
1. Introduction of the US Cancer Biopsy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Cancer Biopsy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Cancer Biopsy Market, By Type
6. US Cancer Biopsy Market, By Application
7. US Cancer Biopsy Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Cancer Biopsy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/